- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Amgen Inc DRC (AMGN)
Amgen Inc DRC stock price live, this page displays TSX AMGN stock exchange data. View the AMGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Amgen Inc DRC real time stock price chart below.
What Is the Amgen Inc DRC Stock Price Today?
The Amgen Inc DRC stock price today is 28.01.
What Is the Stock Symbol for Amgen Inc DRC?
The stock symbol for Amgen Inc DRC is "AMGN."
What Stock Exchange Does Amgen Inc DRC Trade On?
Amgen Inc DRC is listed and trades on the Toronto stock exchange.
Is Amgen Inc DRC a Good Stock to Buy?
Determining whether Amgen Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AMGN quote. (ISIN: CA03116G1090)
What Is the Amgen Inc DRC Stock Price Today?
The Amgen Inc DRC stock price today is 28.01.
What Is the Stock Symbol for Amgen Inc DRC?
The stock symbol for Amgen Inc DRC is "AMGN."
What Stock Exchange Does Amgen Inc DRC Trade On?
Amgen Inc DRC is listed and trades on the Toronto stock exchange.
Is Amgen Inc DRC a Good Stock to Buy?
Determining whether Amgen Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AMGN quote. (ISIN: CA03116G1090)
Toronto
Currency in CAD
28.01
+0.41(+1.49%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.01
28.08
52 wk Range
20.43
28.58
AMGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.0128.08
52 wk Range
20.4328.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.50%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.50%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AMGN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Amgen Inc DRC Company Profile
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Compare AMGN to Peers and Sector
Metrics to compare | AMGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAMGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.1x | 19.2x | −0.5x | |
PEG Ratio | 0.30 | 0.60 | 0.00 | |
Price/Book | 23.2x | 7.0x | 2.6x | |
Price / LTM Sales | 5.5x | 5.0x | 3.3x | |
Upside (Analyst Target) | - | 37.5% | 46.0% | |
Fair Value Upside | Unlock | 8.4% | 5.4% | Unlock |
Earnings
Latest Release
Feb 03, 2026
EPS / Forecast
2.45 / --
Revenue / Forecast
9.87B / --
FAQ
What Is the Amgen DRC (AMGN) Stock Price Today?
The Amgen DRC stock price today is 28.01
What Stock Exchange Does Amgen DRC Trade On?
Amgen DRC is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Amgen DRC?
The stock symbol for Amgen DRC is "AMGN."
Does Amgen DRC Pay Dividends? What’s The Current Dividend Yield?
The Amgen DRC dividend yield is 2.5%.
What Is the Amgen DRC Market Cap?
As of today, Amgen DRC market cap is 274.75B.
What Is Amgen DRC's Earnings Per Share (TTM)?
The Amgen DRC EPS (TTM) is 14.33.
From a Technical Analysis Perspective, Is AMGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Amgen DRC Stock Split?
Amgen DRC has split 0 times.
How Many Employees Does Amgen DRC Have?
Amgen DRC has 31500 employees.
What is the current trading status of Amgen DRC (AMGN)?
As of Feb 18, 2026, Amgen DRC (AMGN) is trading at a price of 28.01, with a previous close of 27.96. The stock has fluctuated within a day range of 28.01 to 28.08, while its 52-week range spans from 20.43 to 28.58.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.